Jasper Therapeutics, Inc.
JSPRW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.
Other share classesJSPR
13F holders, Q3 2022
Institutional positions in Jasper Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- 0 vs. Q2 2022
- Shares held
- 1.49M
- +40.2K (+2.8%) vs. Q2 2022
- Total value
- $135.0K
- −$44.0K (−24.6%) vs. Q2 2022
- New holders
- 0
- 4 more added
- Sold out
- 0
- 2 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JSPRW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $187.1K |
| Q1 2026 | 8 | $371.6K |
| Q4 2025 | 10 | $761.1K |
| Q3 2025 | 9 | $1.09M |
| Q2 2025 | 7 | $383.1K |
| Q1 2025 | 6 | $129.0K |
| Q4 2024 | 5 | $193.1K |
| Q3 2024 | 5 | $625.7K |
| Q2 2024 | 5 | $618.9K |
| Q1 2024 | 4 | $538.5K |
| Q4 2023 | 6 | $236.3K |
| Q3 2023 | 8 | $120.7K |
| Q2 2023 | 11 | $344.6K |
| Q1 2023 | 11 | $430.9K |
| Q4 2022 | 15 | $55.5K |
| Q3 2022 | 15 | $135.0K |
| Q2 2022 | 15 | $179.0K |
| Q1 2022 | 16 | $554.0K |
| Q4 2021 | 16 | $2.97M |
| Q3 2021 | 16 | $3.67M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wolverine Asset Management LLC | 10,646 | $0 | 0.00% | +2,317+27.8% | Added |
| SkyView Investment Advisors, LLC | 302 | $0 | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 14,095 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 19,296 | $1.00K | 0.00% | +15,834+457.4% | Added |
| Cowen and Company, LLC | 32,590 | $2.00K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 29,464 | $2.00K | 0.00% | −4,852−14.1% | Reduced |
| Walleye Capital LLC | 25,059 | $2.00K | 0.00% | 00.0% | Unchanged |
| Equitec Proprietary Markets, LLC | 45,856 | $3.00K | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 61,642 | $4.00K | 0.00% | −66,930−52.1% | Reduced |
| Zazove Associates LLC | 65,456 | $5.00K | 0.00% | 00.0% | Unchanged |
| Privium Fund Management B.V. | 98,102 | $6.00K | 0.00% | +91+0.1% | Added |
| Tenor Capital Management Co., L.P. | 250,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Owl Creek Asset Management, L.P. | 374,833 | $22.0K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $36.0K | 0.00% | – | – |
| Ionic Capital Management LLC | 459,391 | $36.0K | 0.01% | +93,746+25.6% | Added |